Growth Metrics

Forte Biosciences (FBRX) Change in Acquisitions & Divestments (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Change in Acquisitions & Divestments for 5 consecutive years, with $12.7 million as the latest value for Q1 2020.

  • Quarterly Change in Acquisitions & Divestments fell 54.3% to $12.7 million in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $78.4 million through Mar 2020, down 10.21% year-over-year, with the annual reading at $36.4 million for FY2025, N/A changed from the prior year.
  • Change in Acquisitions & Divestments for Q1 2020 was $12.7 million at Forte Biosciences, down from $16.8 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $27.8 million in Q1 2019, with the low at $8.3 million in Q1 2016.
  • Average Change in Acquisitions & Divestments over 5 years is $15.7 million, with a median of $13.6 million recorded in 2017.
  • The sharpest move saw Change in Acquisitions & Divestments skyrocketed 206.33% in 2019, then plummeted 54.3% in 2020.
  • Over 5 years, Change in Acquisitions & Divestments stood at $11.4 million in 2016, then fell by 3.13% to $11.1 million in 2017, then surged by 74.63% to $19.3 million in 2018, then fell by 12.94% to $16.8 million in 2019, then fell by 24.43% to $12.7 million in 2020.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $12.7 million, $16.8 million, and $27.7 million for Q1 2020, Q4 2019, and Q3 2019 respectively.